Safety and Efficacy Study of Everolimus to Treat BK Virus Infection in Kidney Transplant Recipients

NCT01624948 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

40

Enrollment

OTHER

Sponsor class

Conditions

BK Virus Infection

Interventions

DRUG: Everolimus
DRUG: Mycophenolic acid dose reduction

Sponsor

University of California, San Francisco